Conference Coverage

Gap in osteoporosis diagnosis and treatment stirs concern


 

AT ASBMR

Pages

Recommended Reading

Updated osteoporosis guideline advocates bisphosphonates, nixes estrogens
MDedge ObGyn
Romosozumab cuts new vertebral fracture risk by 73%, but safety data are concerning
MDedge ObGyn
In Sweden, very few osteoporotic fractures prompt treatment within 12 months
MDedge ObGyn
Product Update: Intrarosa, ZEJULA, Signia Stapling System, TYMLOS, Videssa Breast
MDedge ObGyn
Anabolic agents for osteoporosis have limited role so far
MDedge ObGyn
How to rule out secondary causes of osteoporosis
MDedge ObGyn
2017 Update on female sexual dysfunction
MDedge ObGyn
Study finds low risk for jaw osteonecrosis with denosumab for postmenopausal osteoporosis
MDedge ObGyn
Incidental hip CT scans could serve as osteoporosis screen
MDedge ObGyn
Preferred osteoporosis treatment order with teriparatide, denosumab reaffirmed
MDedge ObGyn

Related Articles